Close

CTI BioPharma (CTIC), Baxalta (BXLT) Complete Pacritinib NDA Submission to U.S. FDA

January 5, 2016 6:20 AM EST Send to a Friend
CTI BioPharma Corp. (CTI BioPharma) (Nasdaq: CTIC) and Baxalta Incorporated (Baxalta) (NYSE: BXLT) announced the completion of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login